Paper · 12433837
Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs.
Onimaru M and 9 others. Circ Res, 2002. Cited by 75 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs. Papers, record 12433837. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12433837
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs.
- PubMed
Topics27
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblast Growth Factor 2 | Major topic |
| Hepatocyte Growth Factor | Major topic |
| Ischemia | Major topic |
| Animals | |
| Blood Flow Velocity | |
| Cell Line | |
| Disease Models, Animal | |
| Fibroblasts | |
| Gene Expression Regulation | |
| Gene Transfer Techniques | |
| Growth Substances | |
| Hindlimb | |
| Humans | |
| Laser-Doppler Flowmetry | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Microcirculation | |
| Muscle, Skeletal | |
| Muscle, Smooth, Vascular | |
| Platelet-Derived Growth Factor | |
| RNA, Messenger | |
| Transcription, Genetic | |
| Up-Regulation |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,585,885 | High-Fat Diet Differentially Regulates Fibroblast Growth Factor Expression in Metabolic Tissues of Young and Aged Male Mice. | J Endocr Soc | 2025 | https://conductscience.org/library/papers/40585885 | PubMed |
| 39,553,576 | The effect of fibroblast growth factor 2 on neovascular vessels depends on the stage of angiogenesis. | Heliyon | 2024 | https://conductscience.org/library/papers/39553576 | PubMed |
| 39,291,265 | Lung epithelial-endothelial-mesenchymal signaling network with hepatocyte growth factor as a hub is involved in bronchopulmonary dysplasia. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39291265 | PubMed |
| 33,072,729 | Effect of Co-culturing Fibroblasts in Human Skeletal Muscle Cell Sheet on Angiogenic Cytokine Balance and Angiogenesis. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/33072729 | PubMed |
| 32,848,736 | Dapagliflozin Promotes Neovascularization by Improving Paracrine Function of Skeletal Muscle Cells in Diabetic Hindlimb Ischemia Mice Through PHD2/HIF-1α Axis. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32848736 | PubMed |
| 32,613,556 | Correlation Between SNPs at the 3'UTR of the FGF2 Gene and Their Interaction with Environmental Factors in Han Chinese Diabetic Peripheral Neuropathy Patients. | J Mol Neurosci | 2021 | https://conductscience.org/library/papers/32613556 | PubMed |
| 32,490,062 | Basic fibroblast growth factor enhances proliferation and hepatocyte growth factor expression of feline mesenchymal stem cells. | Regen Ther | 2020 | https://conductscience.org/library/papers/32490062 | PubMed |
| 30,010,249 | Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/30010249 | PubMed |
| 29,769,197 | Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression. | Cancer Res | 2018 | https://conductscience.org/library/papers/29769197 | PubMed |
| 27,418,463 | Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101. | Sci Rep | 2016 | https://conductscience.org/library/papers/27418463 | PubMed |
1 to 10 of 27
See all 27 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12433837
GET https://conductscience.org/api/papers/v1/12433837/cited_by?page=2